Literature DB >> 23637417

Interleukin-21 is a critical cytokine for the generation of virus-specific long-lived plasma cells.

Mohammed Ata Ur Rasheed1, Donald R Latner, Rachael D Aubert, Tania Gourley, Rosanne Spolski, Carl W Davis, William A Langley, Sang-Jun Ha, Lilin Ye, Surojit Sarkar, Vandana Kalia, Bogumila T Konieczny, Warren J Leonard, Rafi Ahmed.   

Abstract

Long-lived plasma cells that reside in the bone marrow constitutively produce antibody in the absence of antigen and are the cellular basis of durable humoral immunity. The generation of these long-lived plasma cells depends upon a series of highly orchestrated interactions between antigen-specific CD4 T cells and B cells and the formation of germinal centers (GCs). In this study, we have examined the role of the cytokine interleukin-21 (IL-21) in regulating humoral immunity during acute viral infections. Using IL-21 receptor-deficient (IL-21R(-/-)) mice, we found that virus-specific CD4 T cells were generated after infection with lymphocytic choriomeningitis virus (LCMV) and that these CD4 T cells differentiated into T follicular helper (TFH)-like cells in the absence of IL-21 signaling. There was also no defect in the formation of GCs, although after day 15 these GCs disappeared faster in IL-21R(-/-) mice than in wild-type mice. Isotype switching and the initial LCMV-specific IgG response were normal in IL-21R(-/-) mice. However, these mice exhibited a profound defect in generating long-lived plasma cells and in sustaining antibody levels over time. Similar results were seen after infection of IL-21R(-/-) mice with vesicular stomatitis virus and influenza virus. Using chimeric mice containing wild-type or IL-21R(-/-) CD4 T cells and B cells, we showed that both B and CD4 T cells need IL-21 signaling for generating long-term humoral immunity. Taken together, our results highlight the importance of IL-21 in humoral immunity to viruses.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23637417      PMCID: PMC3700268          DOI: 10.1128/JVI.00063-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6.

Authors:  Gaetan Jego; A Karolina Palucka; Jean-Philippe Blanck; Cecile Chalouni; Virginia Pascual; Jacques Banchereau
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

2.  T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells.

Authors:  Tatyana Chtanova; Stuart G Tangye; Rebecca Newton; Nita Frank; Martin R Hodge; Michael S Rolph; Charles R Mackay
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

3.  Generation of nondividing high rate Ig-secreting plasma cells in cultures of human B cells stimulated with anti-CD3-activated T cells.

Authors:  L Vernino; L M McAnally; J Ramberg; P E Lipsky
Journal:  J Immunol       Date:  1992-01-15       Impact factor: 5.422

4.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

5.  Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes.

Authors:  F Rousset; E Garcia; T Defrance; C Péronne; N Vezzio; D H Hsu; R Kastelein; K W Moore; J Banchereau
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

6.  Inhibitory influence of IL-4 on human B cell responsiveness.

Authors:  D F Jelinek; P E Lipsky
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

7.  SAP is required for generating long-term humoral immunity.

Authors:  Shane Crotty; Ellen N Kersh; Jennifer Cannons; Pamela L Schwartzberg; Rafi Ahmed
Journal:  Nature       Date:  2003-01-16       Impact factor: 49.962

8.  Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen.

Authors:  F Rousset; E Garcia; J Banchereau
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

9.  CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function.

Authors:  P Schaerli; K Willimann; A B Lang; M Lipp; P Loetscher; B Moser
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

10.  Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production.

Authors:  D Breitfeld; L Ohl; E Kremmer; J Ellwart; F Sallusto; M Lipp; R Förster
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  54 in total

Review 1.  Role of interleukin-21 in HBV infection: friend or foe?

Authors:  Yongyin Li; Libo Tang; Jinlin Hou
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

2.  Cutting Edge: miR-17-92 Is Required for Both CD4 Th1 and T Follicular Helper Cell Responses during Viral Infection.

Authors:  Tuoqi Wu; Andreas Wieland; Judong Lee; J Scott Hale; Jin-Hwan Han; Xiaojin Xu; Rafi Ahmed
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

Review 3.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

4.  Extending the clinical and immunological phenotype of human interleukin-21 receptor deficiency.

Authors:  Polina Stepensky; Baerbel Keller; Omar Abuzaitoun; Avraham Shaag; Barak Yaacov; Susanne Unger; Maximilian Seidl; Marta Rizzi; Michael Weintraub; Orly Elpeleg; Klaus Warnatz
Journal:  Haematologica       Date:  2014-11-14       Impact factor: 9.941

5.  mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses.

Authors:  Lilin Ye; Junghwa Lee; Lifan Xu; Ata-Ur-Rasheed Mohammed; Weiyan Li; J Scott Hale; Wendy G Tan; Tuoqi Wu; Carl W Davis; Rafi Ahmed; Koichi Araki
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.

Authors:  Raveendra R Kulkarni; Mohammed Ata Ur Rasheed; Siddhartha Kumar Bhaumik; Priya Ranjan; Weiping Cao; Carl Davis; Krishna Marisetti; Sunil Thomas; Shivaprakash Gangappa; Suryaprakash Sambhara; Kaja Murali-Krishna
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

7.  Changing face of vaccination in immunocompromised hosts.

Authors:  Daire O'Shea; Lukas A Widmer; Jörg Stelling; Adrian Egli
Journal:  Curr Infect Dis Rep       Date:  2014-09       Impact factor: 3.725

8.  Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection.

Authors:  Ran He; Shiyue Hou; Cheng Liu; Anli Zhang; Qiang Bai; Miao Han; Yu Yang; Gang Wei; Ting Shen; Xinxin Yang; Lifan Xu; Xiangyu Chen; Yaxing Hao; Pengcheng Wang; Chuhong Zhu; Juanjuan Ou; Houjie Liang; Ting Ni; Xiaoyan Zhang; Xinyuan Zhou; Kai Deng; Yaokai Chen; Yadong Luo; Jianqing Xu; Hai Qi; Yuzhang Wu; Lilin Ye
Journal:  Nature       Date:  2016-08-02       Impact factor: 49.962

9.  Human cytomegalovirus pUL10 interacts with leukocytes and impairs TCR-mediated T-cell activation.

Authors:  Luca Bruno; Mirko Cortese; Giuseppina Monda; Michela Gentile; Stefano Calò; Francesca Schiavetti; Luisanna Zedda; Elena Cattaneo; Diego Piccioli; Mary Schaefer; Eugenio Notomista; Domenico Maione; Andrea Carfì; Marcello Merola; Yasushi Uematsu
Journal:  Immunol Cell Biol       Date:  2016-05-19       Impact factor: 5.126

10.  The transcription factor TCF-1 initiates the differentiation of T(FH) cells during acute viral infection.

Authors:  Lifan Xu; Yi Cao; Zhunyi Xie; Qizhao Huang; Qiang Bai; Xia Yang; Ran He; Yaxing Hao; Haoqiang Wang; Tingting Zhao; Zhonglei Fan; Aijian Qin; Jianqiang Ye; Xinyuan Zhou; Lilin Ye; Yuzhang Wu
Journal:  Nat Immunol       Date:  2015-07-27       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.